176 related articles for article (PubMed ID: 36569097)
1. Coxsackievirus B3 infection induces glycolysis to facilitate viral replication.
Qian Y; Yang Y; Qing W; Li C; Kong M; Kang Z; Zuo Y; Wu J; Yu M; Yang Z
Front Microbiol; 2022; 13():962766. PubMed ID: 36569097
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of iNOS protects cardiomyocytes against coxsackievirus B3-induced cell injury by suppressing autophagy.
Qi L; Xin Q; Wenjun J
Biomed Pharmacother; 2017 Jul; 91():673-679. PubMed ID: 28499238
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
Zhou L; He X; Gao B; Xiong S
J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Model Systems of Coxsackievirus B3-Induced Myocarditis: Comparison of Commonly Used Cell Lines and Characterization of CVB3-Infected iCell
Kraft L; Sauter M; Seebohm G; Klingel K
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578416
[TBL] [Abstract][Full Text] [Related]
5. Autophagosome supports coxsackievirus B3 replication in host cells.
Wong J; Zhang J; Si X; Gao G; Mao I; McManus BM; Luo H
J Virol; 2008 Sep; 82(18):9143-53. PubMed ID: 18596087
[TBL] [Abstract][Full Text] [Related]
6. Coxsackievirus B3-induced calpain activation facilitates the progeny virus replication via a likely mechanism related with both autophagy enhancement and apoptosis inhibition in the early phase of infection: an in vitro study in H9c2 cells.
Li M; Wang X; Yu Y; Yu Y; Xie Y; Zou Y; Ge J; Peng T; Chen R
Virus Res; 2014 Jan; 179():177-86. PubMed ID: 24177271
[TBL] [Abstract][Full Text] [Related]
7. ISG15 blocks cardiac glycolysis and ensures sufficient mitochondrial energy production during Coxsackievirus B3 infection.
Bredow C; Thery F; Wirth EK; Ochs S; Kespohl M; Kleinau G; Kelm N; Gimber N; Schmoranzer J; Voss M; Klingel K; Spranger J; Renko K; Ralser M; Mülleder M; Heuser A; Knobeloch KP; Scheerer P; Kirwan J; Brüning U; Berndt N; Impens F; Beling A
Cardiovasc Res; 2024 May; 120(6):644-657. PubMed ID: 38309955
[TBL] [Abstract][Full Text] [Related]
8. Metabolic reprogramming as a novel therapeutic target for Coxsackievirus B3.
Kuk MU; Ga YJ; Kim YJ; Park JY; Song ES; Lee H; Lee YH; Ko G; Kim JK; Yeh JY; Kwon HW; Byun Y; Park JT
Anim Cells Syst (Seoul); 2022; 26(6):275-282. PubMed ID: 36605593
[TBL] [Abstract][Full Text] [Related]
9. Virus-Host Interactions of Enteroviruses and Parvovirus B19 in Myocarditis.
Ho HT; Peischard S; Strutz-Seebohm N; Seebohm G
Cell Physiol Biochem; 2021 Nov; 55(6):679-703. PubMed ID: 34791861
[TBL] [Abstract][Full Text] [Related]
10. Influenza A Virus (H1N1) Infection Induces Glycolysis to Facilitate Viral Replication.
Ren L; Zhang W; Zhang J; Zhang J; Zhang H; Zhu Y; Meng X; Yi Z; Wang R
Virol Sin; 2021 Dec; 36(6):1532-1542. PubMed ID: 34519916
[TBL] [Abstract][Full Text] [Related]
11. Activation of AMPK restricts coxsackievirus B3 replication by inhibiting lipid accumulation.
Xie W; Wang L; Dai Q; Yu H; He X; Xiong J; Sheng H; Zhang D; Xin R; Qi Y; Hu F; Guo S; Zhang K
J Mol Cell Cardiol; 2015 Aug; 85():155-67. PubMed ID: 26055448
[TBL] [Abstract][Full Text] [Related]
12. CVB3 Nonstructural 2A Protein Modulates SREBP1a Signaling via the MEK/ERK Pathway.
Wang L; Xie W; Zhang L; Li D; Yu H; Xiong J; Peng J; Qiu J; Sheng H; He X; Zhang K
J Virol; 2018 Dec; 92(24):. PubMed ID: 30258014
[TBL] [Abstract][Full Text] [Related]
13. Coxsackievirus B3 engineered to contain microRNA targets for muscle-specific microRNAs displays attenuated cardiotropic virulence in mice.
He F; Yao H; Wang J; Xiao Z; Xin L; Liu Z; Ma X; Sun J; Jin Q; Liu Z
J Virol; 2015 Jan; 89(2):908-16. PubMed ID: 25339771
[TBL] [Abstract][Full Text] [Related]
14. Expression of
Ishfaq M; Bashir N; Riaz SK; Manzoor S; Khan JS; Bibi Y; Sami R; Aljahani AH; Alharthy SA; Shahid R
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328104
[TBL] [Abstract][Full Text] [Related]
15. CircDDX17 enhances coxsackievirus B3 replication through regulating miR-1248/NOTCH receptor 2 axis.
Liu T; Li Y; Chen S; Wang L; Liu X; Yang Q; Wang Y; Qiao X; Tong J; Deng X; Shao S; Wang H; Shen H
Front Microbiol; 2022; 13():1012124. PubMed ID: 36338034
[TBL] [Abstract][Full Text] [Related]
16. TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production.
Liu H; Li M; Song Y; Xu W
Front Immunol; 2018; 9():2479. PubMed ID: 30410495
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis.
Van Linthout S; Savvatis K; Miteva K; Peng J; Ringe J; Warstat K; Schmidt-Lucke C; Sittinger M; Schultheiss HP; Tschöpe C
Eur Heart J; 2011 Sep; 32(17):2168-78. PubMed ID: 21183501
[TBL] [Abstract][Full Text] [Related]
18. The role of autophagy during coxsackievirus infection of neural progenitor and stem cells.
Tabor-Godwin JM; Tsueng G; Sayen MR; Gottlieb RA; Feuer R
Autophagy; 2012 Jun; 8(6):938-53. PubMed ID: 22751470
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926
[TBL] [Abstract][Full Text] [Related]
20. A Kidnapping Story: How Coxsackievirus B3 and Its Host Cell Interact.
Peischard S; Ho HT; Theiss C; Strutz-Seebohm N; Seebohm G
Cell Physiol Biochem; 2019; 53(1):121-140. PubMed ID: 31230428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
